News 3 Oct 2025 DNDi 2025 Projects of the Year recognize contributions of DNDi teams and partners working to deliver urgently needed innovations for people affected by Chagas disease and river blindness
In the media 30 Sep 2025 Le développement de médicaments pour les maladies négligées doit tenir compte des enfants Nature Africa
Scientific articles 30 Sep 2025 New regimens of benznidazole for the treatment of chronic Chagas disease in adult participants in indeterminate form or with mild cardiac progression (NuestroBen study): protocol for a phase III randomised, multicentre non-inferiority clinical trial BMJ Open
Scientific articles 29 Sep 2025 Performance evaluation of rapid diagnostic tests for Chagas disease in Jutiapa, Guatemala Journal of the Brazilian Society of Tropical Medicine
Press releases 23 Sep 2025 Open-science approach delivers a promising pre-clinical candidate for broad-spectrum coronavirus antiviral
Scientific articles 22 Sep 2025 Mass balance, pharmacokinetics, metabolism, and excretion of radiolabeled acoziborole, a potential novel treatment for human African trypanosomiasis, following single microtracer oral dose to humans Antimicrobial Agents and Chemotherapy
Press releases 15 Sep 2025 Switzerland renews commitment to DNDi to advance medical innovation for neglected patients
Scientific articles 8 Sep 2025 Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: a secondary analysis of individual patient data from two proof-of-concept trials The Lancet Microbe
Press releases 22 Aug 2025 DNDi receives Japan’s Hideyo Noguchi Africa Prize 2025 for its work to develop new treatments for neglected diseases in Africa
Statements 21 Aug 2025 DNDi’s briefing note for the 75th Session of the World Health Organization Regional Committee for Africa
Press releases 23 Sep 2025 Open-science approach delivers a promising pre-clinical candidate for broad-spectrum coronavirus antiviral
Press releases 15 Sep 2025 Switzerland renews commitment to DNDi to advance medical innovation for neglected patients
Press releases 22 Aug 2025 DNDi receives Japan’s Hideyo Noguchi Africa Prize 2025 for its work to develop new treatments for neglected diseases in Africa
Press releases 23 Jul 2025 AN2 Therapeutics and DNDi collaborate on clinical development of promising new oral compound to treat chronic Chagas disease
Press releases 10 Jul 2025 New HIV project in the DRC brings life-saving care closer to people with advanced HIV disease
Press releases 1 Jul 2025 Thailand’s Government Pharmaceutical Organization (GPO) partners with DNDi and Pharco to register an effective and affordable hepatitis C treatment
Press releases 13 Jun 2025 K-MEDI and DNDi have initiated collaborative R&D to develop a treatment for neglected diseases
Press releases 13 Jun 2025 Serum Institute of India signs a memorandum of understanding (MoU) with DNDi to advance the development of a new treatment for dengue in low- and middle-income countries
Press releases 5 Jun 2025 Colombia becomes first country to recommend rapid tests to diagnose Chagas disease
Press releases 22 May 2025 Six African nations commit to eliminate deadly neglected disease visceral leishmaniasis
Press releases 13 May 2025 First all-oral treatment for a rare but deadly strain of sleeping sickness now available and being used to treat patients in endemic countries in Africa
Press releases 24 Apr 2025 Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease
Press releases 23 Apr 2025 DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease
Press releases 15 Apr 2025 New treatment for cryptococcal meningitis enters Phase II trial as global HIV funding cuts threaten to cause a massive increase in advanced HIV disease
Press releases 18 Mar 2025 DNDi welcomes GHIT support for new collaboration with Shionogi to identify novel drug candidates for neglected Chagas disease
Press releases 13 Feb 2025 DNDi announces organizational strategy update and strengthened executive team
